Dentsply Sirona (NSDQ:XRAY) shares took a marginal dip today on fourth-quarter results that had mixed results compared to the consensus forecast.
The York, Pa.–based dental equipment maker posted profits of $102 million, or 46¢ per share, on sales of $1.1 billion for the three months ended Dec. 31, 2019, for a monstrous bottom-line gain from $2 million in Q4 2018 profits on sales growth of 4.9%.
Adjusted to exclude one-time items, earnings per share were 73¢, 2¢ behind Wall Street, where analysts were looking for sales of $1.09 billion.
“Our results today clearly indicate that our restructuring plan is delivering on its promise, as evidenced by the uptick in innovation in 2019, our reenergized sales teams, and benefits stemming from our portfolio-shaping activities,” Dentsply Sirona CEO Don Casey said in a news release. “We still have a lot of work to do, but our results clearly suggest that our performance is on track and we expect the ongoing execution of our plan to continue to deliver strong financial performance as we move forward.”
Dentsply Sirona said it expects to log adjusted EPS of $2.55 to $2.80 in 2020, and set its sales guidance for the year at a range of $4.10 billion to $4.15 billion. The company said its guidance incorporates a revenue impact of between $60 million to $70 million and an EPS impact of 10¢ to 12¢ due to the coronavirus.
XRAY shares were down 0.3% at $49.09 per share in midday trading today.
